Genome-scale models for microbial factories

Industrial Biotechnology

Volumn 9, Issue 4, 2013, Pages 177-178

  Price, Nathan D ^a  

^a INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84881485174     PISSN: 15509087     EISSN: None     Source Type: Journal    
DOI: 10.1089/ind.2013.1586     Document Type: Note

References (12)

1. Wurm FM. Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol 2004;22(11):1393-1398. (Pubitemid 39482858)
2. Westfall PJ, Pitera DJ, Lenihan JR, et al. Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin. Proc Natl Acad Sci 2012;109(3):E111-118.
3. Mann MS, Lutke-Eversloh T. Thiolase engineering for enhanced butanol production in Clostridium acetobutylicum. Biotechnol Bioeng 2013;110(3):887-897.
4. Gulevich AY, Skorokhodova AY, Sukhozhenko AV, et al. Metabolic engineering of Escherichia coli for 1-butanol biosynthesis through the inverted aerobic fatty acid beta-oxidation pathway. Biotechnol Lett 2012;34(3):463-469.
5. Larkum AW, Ross IL, Kruse O, and Hankamer B. Selection, breeding and engineering of microalgae for bioenergy and biofuel production. Trends Biotechnol 2012;30(4):198-205.
6. Yim H, Haselbeck R, Niu W, et al. Metabolic engineering of Escherichia coli for direct production of 1,4-butanediol. Nat Chem Biol 2011;7(7):445-452.
7. Paddon CJ, Westfall PJ, Pitera DJ, et al. High-level semi-synthetic production of the potent antimalarial artemisinin. Nature 2013;496(7446):528- 532.
8. Change The World: Sapphire Energy's Green Crude Farm, Illustrated. Available at: www.sapphireenergy.com/news-article/1212040-change-the- worldsapphire- energy-s-green (Last accessed July 2013).
9. Thiele I, Palsson BO. A protocol for generating a high-quality genome-scale metabolic reconstruction. Nat Protoc 2010;5(1):93-121.
10. Price ND, Reed JL, Palsson BO. Genome-scale models of microbial cells: Evaluating the consequences of constraints. Nat Rev Microbiol 2004;2(11):886-897. (Pubitemid 39567269)
11. Milne CB, Kim PJ, Eddy JA, Price ND. Accomplishments in genome-scale in silico modeling for industrial and medical biotechnology. Biotechnol J 2009;4(12):1653-1670.
12. Schellenberger J, Que R, Fleming RM, et al. Quantitative prediction of cellular metabolism with constraint-based models: The COBRA Toolbox v2.0. Nat Protoc 2011;6(9):1290-1307.